CardioCel - New Scientific Papers, page-39

Tomboy

Who cares about the immune system of mice? How is it relevant to AHZ’s current situation? Focus on the facts.

With ~ 10mil in the bank and a half year operating loss of 11mil for the half year 31/12/2014. It is more than likely that a capital raising will be required before this FY is out. Now how much do they need to raise? Let’s say 20mil which should keep them going for another 12months and lets hope they can turn a profit within this time frame however unlikely that may be given they’ll need to increase current turnover by at least 400%. Now say they raise at 0.05 to 0.10 to raise 20mil that’s another 200 to 400 m shares which is going to have dilution factor around 20%.

Given there’s nothing tangible with the vaccine segment at this stage of course the market is going to value it at 0 until there’s something concrete this will remain the case.

Say we take shares outstanding 1,440,000,000 current price 0.087 and sector P/E 25 because AHZ doesn’t have one. Lol. To justify current share price AHZ should be turning a profit of approx. 5 million ie = 1.440 m * 0.087 * 25 = 5,011,200. For me I don’t see this happening any time soon.

With this being said the slide in share price is not of great surprise to myself.